American National Insurance’s Flexion Therapeutics, Inc. FLXN Stock Holding History

American National Insurance’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-336,250	Closed	-$2.05M	–	328
2021 Q3	$2.05M	Sell	336,250 -365	-0.1%	-$2.27K	0.08%	211
2021 Q2	$2.77M	Sell	336,615 -635	-0.2%	-$5.4K	0.1%	199
2021 Q1	$3.02M	Hold	337,250	–	–	0.12%	189
2020 Q4	$3.89M	Hold	337,250	–	–	0.17%	165
2020 Q3	$3.51M	Hold	337,250	–	–	0.17%	146
2020 Q2	$4.43M	Buy	+337,250	New	+$3.5M	0.23%	120

American National Insurance's FLXN Position: Q4 2021 in Review

American National Insurance sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 336,250 shares — an estimated $2.05M sold.

American National Insurance first reported a position in FLXN in Q2 2020 and held it in 6 quarters. The position peaked at $4.43M in Q2 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

American National Insurance reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
American National Insurance sold 336,250 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $2.05M.
American National Insurance first reported a position in Flexion Therapeutics, Inc. in Q2 2020 and held it in 6 quarters.
American National Insurance's Flexion Therapeutics, Inc. position peaked at $4.43M in Q2 2020.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on American National Insurance's 13F filing for Q4 2021, filed 9 Feb 2022.